13F-HR: Pfizer Inc. 13F Holdings Report Q1 2026

Pfizer Inc. filed its Form 13F for the quarter ended March 31, 2026, detailing its institutional investment holdings.

Summary

• Pfizer Inc. has submitted its Form 13F-HR filing for the quarter ending March 31, 2026.
• The report lists a total of 21 investment holdings.
• The aggregate value of these holdings is $238,775,816.
• All holdings are reported by Pfizer Inc. as the sole manager.
• The filing includes holdings in various biotechnology and pharmaceutical companies.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of investment holdings without new strategic announcements or financial performance data.

Positives

• Pfizer Inc. has a diverse portfolio of 21 distinct investment holdings.
• The total value of the reported holdings is substantial at $238,775,816.
• Pfizer Inc. exercises sole discretion over all reported investments, indicating a clear investment strategy.

Future Outlook

This filing is a historical report of investment holdings as of March 31, 2026, and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Pfizer Inc.'s Form 13F filing provides a snapshot of its investment strategy in the biotechnology and pharmaceutical sectors, reflecting potential strategic interests or diversification efforts within the broader healthcare industry.

Key Dates

Keywords

Pfizer Inc., Form 13F, Institutional Investment Manager, Holdings Report, Biotechnology, Pharmaceuticals, Investment Portfolio, SEC Filing